These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9804691)

  • 1. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
    Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
    J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
    Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
    J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).
    Dutta AK; Ryan W; Thomas BF; Singer M; Compton DR; Martin BR; Razdan RK
    Bioorg Med Chem; 1997 Aug; 5(8):1591-600. PubMed ID: 9313864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.
    Eissenstat MA; Bell MR; D'Ambra TE; Alexander EJ; Daum SJ; Ackerman JH; Gruett MD; Kumar V; Estep KG; Olefirowicz EM
    J Med Chem; 1995 Aug; 38(16):3094-105. PubMed ID: 7636873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
    J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
    Xie XQ; Eissenstat M; Makriyannis A
    Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
    Jansen EM; Haycock DA; Ward SJ; Seybold VS
    Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
    Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
    Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
    Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
    NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
    Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
    Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
    J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
    Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
    Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
    Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
    Houston DB; Howlett AC
    Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
    Stark S; Pacheco MA; Childers SR
    Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
    Devlin MG; Christopoulos A
    J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM; Paria BC; Dey SK
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction.
    Shim JY; Howlett AC
    J Chem Inf Model; 2006; 46(3):1286-300. PubMed ID: 16711748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Spicy Story of Cannabimimetic Indoles.
    Howlett AC; Thomas BF; Huffman JW
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.